Literature DB >> 17884969

Cartilage oligometric matrix protein-angiopoietin-1 promotes revascularization through increased survivin expression in dermal endothelial cells of skin grafts in mice.

Seung-Jae Byun1, Kyu-Sil Choi, Sung Hoon Park, Nam Woo Cho, Chang Hyun Yoo, Ki Jung Yun, Young Jun Koh, Gou Young Koh, Byung Jun So, Kwon-Ha Yoon.   

Abstract

The present study examined the effects of cartilage oligometric matrix protein angiopoietin-1 (COMP-Ang1) on the revascularization of mice skin grafts. Full-thickness skin grafts were autotransferred into BALB/c mice. The donor grafts were soaked in COMP-Ang1 protein (50 mug/ml, n = 10) or in bovine serum albumin (BSA) (50 mug/ml, n = 10) dissolved in 1 ml of sterile, phosphate-buffered saline for 5 minutes before transfer. Revascularization of the grafts was monitored using an intravital microscope on postoperative days 3, 4, and 5. Morphological and immunohistochemical analyses were performed to evaluate platelet-endothelial cell adhesion molecule-1 and survivin expression and apoptotic signal in the transplanted grafts. Grafts soaked in COMP-Ang1 (COMP-Ang1 group) showed significantly increased revascularization compared with grafts soaked in BSA (BSA group) on intravital microscopy and platelet-endothelial cell adhesion molecule-1 staining. The COMP-Ang1 group showed a significant increase of survivin expression in the endothelial cells and a reduction of apoptotic signal in comparison to the BSA group. Therefore, we believe that COMP-Ang1 provides the therapeutic benefit of enhancing the survival of vascular endothelial cells during transplantation of skin graft.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884969      PMCID: PMC2043528          DOI: 10.2353/ajpath.2007.070142

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Protection by vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation.

Authors:  T Moriga; S Arii; Y Takeda; H Furuyama; M Mizumoto; A Mori; K Hanaki; T Nakamura; M Fujioka; M Imamura
Journal:  Transplantation       Date:  2000-01-15       Impact factor: 4.939

2.  Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis.

Authors:  Jennifer M Capla; Daniel J Ceradini; Oren M Tepper; Matthew J Callaghan; Kirit A Bhatt; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Plast Reconstr Surg       Date:  2006-03       Impact factor: 4.730

3.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

Authors:  G Thurston; C Suri; K Smith; J McClain; T N Sato; G D Yancopoulos; D M McDonald
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

4.  MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes.

Authors:  T Minamino; T Yujiri; P J Papst; E D Chan; G L Johnson; N Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration.

Authors:  Z Kryger; F Zhang; T Dogan; C Cheng; W C Lineaweaver; H J Buncke
Journal:  Br J Plast Surg       Date:  2000-04

6.  Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway.

Authors:  A Papapetropoulos; D Fulton; K Mahboubi; R G Kalb; D S O'Connor; F Li; D C Altieri; W C Sessa
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

7.  COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model.

Authors:  Won Kim; Sang-Ok Moon; Sang Yong Lee; Kyu Yun Jang; Chung-Hyun Cho; Gou Young Koh; Kyu-Sil Choi; Kwon-Ha Yoon; Mi Jeong Sung; Duk Hoon Kim; Sik Lee; Kyung Pyo Kang; Sung Kwang Park
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

8.  c-Jun triggers apoptosis in human vascular endothelial cells.

Authors:  N Wang; L Verna; S Hardy; Y Zhu; K S Ma; M J Birrer; M B Stemerman
Journal:  Circ Res       Date:  1999-09-03       Impact factor: 17.367

9.  COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model.

Authors:  Chung-Hyun Cho; Hoon-Ki Sung; Kyung-Tae Kim; Hyae Gyeong Cheon; Goo Taeg Oh; Hyo Jeong Hong; Ook-Joon Yoo; Gou Young Koh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-16       Impact factor: 11.205

10.  Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2.

Authors:  Pipsa Saharinen; Katja Kerkelä; Niklas Ekman; Marie Marron; Nicholas Brindle; Gyun Min Lee; Hellmut Augustin; Gou Young Koh; Kari Alitalo
Journal:  J Cell Biol       Date:  2005-04-25       Impact factor: 10.539

View more
  4 in total

1.  Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Authors:  Qiuying Cheng; Xiang Ling; Andrew Haller; Takahito Nakahara; Kentaro Yamanaka; Aya Kita; Hiroshi Koutoku; Masahiro Takeuchi; Michael G Brattain; Fengzhi Li
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

3.  Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.

Authors:  Fengzhi Li; Qiuying Cheng; Xiang Ling; Aimee Stablewski; Lei Tang; Barbara A Foster; Candace S Johnson; Youcef M Rustum; Carl W Porter
Journal:  Am J Pathol       Date:  2010-02-04       Impact factor: 4.307

4.  The effect of angiopoietin-1 upregulation on the outcome of acute ischaemic stroke in rodent models: A meta-analysis.

Authors:  Joseph V Moxon; Alexandra F Trollope; Brittany Dewdney; Catherine de Hollander; Domenico R Nastasi; Jane M Maguire; Jonathan Golledge
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-04       Impact factor: 6.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.